Affiliation:
1. Department of Otolaryngology – Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
Abstract
Summary
Allergic rhinitis is a common airway disease characterized by hypersensitivity, exudation, hypersecretion, inflammatory cell infiltration and remodelling. Intranasal glucocorticosteroids are the most effective drugs for controlling the inflammation caused by allergic rhinitis. Glucocorticosteroids exert anti-inflammatory effects through at least two pathways: the transactivation pathway and the transrepression pathway. Glucocorticosteroids also exert regulatory functions by inducing regulatory cytokines and forkhead box P3 (FoxP3+) regulatory T cells. Evidence suggests that intranasal glucocorticosteroids control not only nasal symptoms but also ocular symptoms. In contrast to sedating H1 receptor antagonists, intranasal glucocorticosteroids can improve impaired performance symptoms, such as daytime sleepiness, associated with allergic rhinitis. Recent studies suggest that intranasal glucocorticosteroids might also be useful for the prophylactic treatment of pollinosis; this possibility is supported by the molecular mechanism of the anti-inflammatory action of glucocorticosteroids. These findings suggest that intranasal glucocorticosteroids might be positioned as first-line drugs for the treatment of both perennial and seasonal allergic rhinitis.
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Reference99 articles.
1. Allergic rhinitis and its impact on asthma (ARIA) 2008 update;Bousquet;Allergy,2008
2. Allergic rhinitis: a disease remodeling the upper airways?;Bousquet;J Allergy Clin Immunol,2004
3. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops;Kimmerle;Am J Med,1985
4. Merits and demerits of steroid – different whole body and limited part administering;Masuyama;J Jpn Immunol Allergol Otolaryngol,2000
Cited by
77 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献